Z-LE(OMe)HD(OMe)-FMK (Caspase 9 Inhibitor)

Name: Z-LE(OMe)HD(OMe)-FMK (Caspase 9 Inhibitor)
Brand: Novus Biologicals
SKU: NBP2-29398

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-29398

Submit a review

Product Datasheet / COA / Protocols & Manuals

100% Guarantee

Product Specifications
Preparation & Storage
Background
Product Documents
Specific Notices

Key Product Details

Applications

Functional Assay

Product Specifications

Details of Functionality

Molecular Weight: 690 (not including TFA salt)
Formula: C32H43N6O10F
Mass Spec: M+1=691.2
TLC: B:8, A:1, W:1, Rf:065
NMR: All functional groups are present

Application Notes

1. This inhibitor is designed as a methyl ester to facilitate cell permeability. If the intended use is on purified or recombinant enzymes, esterase should be added to generate the free carboxyl groups. Please contact us for more details.
2. For in-vivo or in-vitro experiments extending longer than 12 hrs, fresh inhibitor may have to be added toculture medium or injected into animals.

Formulation, Preparation, and Storage

Formulation

Form: Tan crystals, (crystalline gel)
Store well desiccated and under nitrogen, very hygroscopic
For extra precaution, store the solid product under a blanket of nitrogen because it is hygroscopic material.

Concentration

Concentration is not relevant for this product. Please see the protocols for proper use of this product.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: Z-LE(OMe)HD(OMe)-FMK

Members of the caspase family play key roles in apoptosis and inflammation. Z-LE(OMe)HD(OMe)-FMK is a cellpermeable caspase peptide inhibitor that irreversibly binds to the catalytic site of caspases proteases, and inhibits caspase mediated apoptosis by preventing the processing of pro-caspases to their active forms (reviewed in 1-3). ZLEHD- FMK was first described is an irreversible and cell permeable inhibitor of Caspase 9. The Z-LE(OMe)HD(OMe)-FMK peptide is O-methylated in the P1 and P3 positions providing enhanced stability and increased cell permeability. Z-LE(OMe)HD(OMe)-FMK (Z-LEHD-FMK) is typically used in assays to inhibit apoptosis. Z-LEHD-FMK has been used in many different types of apoptosis assays and published using a number of model system. Users may want to consult the literature for additional information regarding applications for Z-LEHDFMK. Z-LEHD-FMK is recommended as a search term for identifying references in PubMed using this peptide inhibitor.

Alternate Names

Z-LE(OMe)HD(OMe)-FMK, Z-LEHD-FMK, Z-LEHD-FMK [Z-Leu-Glu(OMe)-His-Asp(OMe)-FMK, Z-Leu-Glu(OMe)-His-Asp(OMe)-FMK.

Additional Z-LE(OMe)HD(OMe)-FMK Products

Product Documents for Z-LE(OMe)HD(OMe)-FMK (Caspase 9 Inhibitor)

Product Datasheets

Download Product Datasheets

Protocols & Manuals

Download NBP2-29398 - Protocol

Download Product Handling Protocol

COA

Product Specific Notices for Z-LE(OMe)HD(OMe)-FMK (Caspase 9 Inhibitor)

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Inhibitors are guaranteed for 1 year from date of receipt.

Citations
Reviews